Who is sponsoring NCT03871881?

NCT03871881 is sponsored by University of Aarhus.

What drugs are being tested in NCT03871881?

Interventions in NCT03871881: Magnetic Resonance Imaging, Neuropsychological assessment.

What condition does NCT03871881 study?

NCT03871881 studies Heart Defects, Congenital.

Is NCT03871881 still recruiting?

NCT03871881 is currently status unknown. Last updated 10 May 2021.

Last reviewed 2021-05-10 · How we verify

NCT03871881

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Congenital Heart Disease on Neurodevelopmental Outcome

Status unknown Last updated 10 May 2021

What this trial tests

trial testing Magnetic Resonance Imaging in Heart Defects, Congenital in 120 participants. Status unknown.

Timeline

1 July 2017

Primary endpoint
1 August 2023

1 August 2023

Quick facts

Lead sponsor	University of Aarhus
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	120
Start date	1 July 2017
Primary completion	1 August 2023
Estimated completion	1 August 2023
Sites	1 location across Denmark

Drugs / interventions tested

Magnetic Resonance Imaging
Neuropsychological assessment

Conditions studied

Heart Defects, Congenital — all drugs for Heart Defects, Congenital →

Sponsor

University of Aarhus

Who can join

Adults 18 to 42, any sex, with Heart Defects, Congenital. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The project aims toward clarifying the underlying mechanism and the long-term impact of congenital heart disease on neurodevelopment.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Neuropsychological Status and Structural Brain Imaging in Adults With Simple Congenital Heart Defects Closed in Childhood.
Asschenfeldt B, Evald L, Heiberg J, Salvig C, et al · · 2020 · cited 42× · PMID 32427039 · DOI 10.1161/jaha.120.015843
Abnormal Left-Hemispheric Sulcal Patterns in Adults With Simple Congenital Heart Defects Repaired in Childhood.
Asschenfeldt B, Evald L, Yun HJ, Heiberg J, et al · · 2021 · cited 12× · PMID 33745293 · DOI 10.1161/jaha.120.018580
Hyperactivity and Inattention in Young Patients Born With an Atrial Septal or Ventricular Septal Defect.
Lau-Jensen SH, Asschenfeldt B, Evald L, Hjortdal VE. · · 2021 · cited 11× · PMID 34938699 · DOI 10.3389/fped.2021.786638
Altered Cerebral Microstructure in Adults With Atrial Septal Defect and Ventricular Septal Defect Repaired in Childhood.
Asschenfeldt B, Evald L, Salvig C, Heiberg J, et al · · 2022 · cited 4× · PMID 35699183 · DOI 10.1161/jaha.121.020915
Self- and proxy-reported impaired social interaction in young adults with simple congenital heart defects.
Lau-Jensen SH, Asschenfeldt B, Evald L, Hjortdal VE. · · 2023 · cited 1× · PMID 37744440 · DOI 10.3389/fped.2023.1165820

Verify or expand the search:

Other trials of Magnetic Resonance Imaging

Trials testing the same drug.

NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
NCT07229339 — Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07441681 — Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive · Phase 3 · not yet recruiting
NCT07147231 — Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cem · Phase 1, PHASE2 · recruiting
NCT06448286 — PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glio · Phase 3 · not yet recruiting

Other recruiting trials for Heart Defects, Congenital

Currently open trials in the same condition.

NCT06003023 — Congenital Heart Disease Physical Activity Lifestyle Study V.2 · NA · recruiting
NCT05709470 — Mind the Heart - Mental Health in Children and Adolescents With Congenital Heart Defects · recruiting
NCT05330338 — Genetics of Ventriculo-arterial Discordance · NA · active not recruiting
NCT06089902 — European Prospective Registry on Anomalous Aortic Origin of the Coronary Arteries · recruiting

Other University of Aarhus trials

Trials by the same sponsor.

NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03871881 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
Last refreshed: 10 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03871881.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing